Table 5.
Comparison of anthropometric, Glycemic, Lipid profile, and Neuro‐cognitive factors pre‐ and post‐AOL advance meditation with increased Po2 (n = 31)
| Parameters | M | M | t‐value | CI (95%) | p‐value | |
|---|---|---|---|---|---|---|
| Minimum | Maximum | |||||
| Weight | 72.32 ± 11.45 | 71.68 ± 11.03 | 1.76 | −0.10 | 1.39 | .089 |
| BMI | 26.81 ± 3.73 | 26.58 ± 3.66 | 1.65 | −0.05 | 0.51 | .109 |
| Waist | 94.26 ± 9.88 | 93.23 ± 10.06 | 1.01 | −1.06 | 3.13 | .323 |
| HIP | 102.94 ± 8.05 | 101.00 ± 14.60 | 0.96 | −2.18 | 6.05 | .344 |
| Systolic | 143.65 ± 20.22 | 138.26 ± 16.43 | 2.56 | 1.10 | 9.68 | .016 |
| Diastolic | 96.06 ± 14.27 | 97.00 ± 19.75 | −0.23 | −9.36 | 7.49 | .822 |
| PO2 | 88.26 ± 2.70 | 91.39 ± 2.26 | −6.66 | −4.09 | −2.17 | <.001 |
| Pulse Rate | 86.00 ± 11.94 | 83.65 ± 11.24 | 1.01 | −2.43 | 7.14 | .323 |
| Glucose | 78.77 ± 27.52 | 82.52 ± 29.61 | −5.90 | −5.04 | −2.45 | <.001 |
| Cholesterol | 202.23 ± 30.56 | 199.71 ± 37.01 | 0.72 | −4.64 | 9.68 | .478 |
| Triglycerides | 191.97 ± 66.32 | 185.32 ± 51.74 | 1.54 | −2.15 | 15.44 | .133 |
| HDL | 40.26 ± 4.98 | 40.00 ± 4.13 | 0.38 | −1.11 | 1.63 | .704 |
| LDL | 123.35 ± 28.41 | 122.81 ± 35.68 | 0.15 | −6.91 | 8.01 | .882 |
| CDL/HDL | 4.90 ± 0.83 | 5.00 ± 0.97 | −0.57 | −0.44 | 0.25 | .572 |
| LDL/HDL | 3.00 ± 0.58 | 3.13 ± 0.92 | −0.89 | −0.42 | 0.17 | .380 |
| VLDL | 38.32 ± 13.30 | 36.90 ± 10.34 | 1.62 | −0.37 | 3.21 | .117 |
| HB | 16.61 ± 1.71 | 16.23 ± 1.50 | 3.01 | 0.12 | 0.65 | .005 |
| STAI | 34.32 ± 8.40 | 28.65 ± 7.96 | 4.60 | 3.16 | 8.20 | <.001 |
| MWB | 58.43 ± 7.60 | 60.63 ± 7.77 | −1.84 | −4.65 | 0.25 | .076 |
| OHQ | 133.03 ± 17.52 | 138.90 ± 16.85 | −1.94 | −12.04 | 0.30 | .061 |
| SLCT | 28.18 ± 8.96 | 26.96 ± 7.77 | 0.63 | −2.75 | 5.18 | .535 |
Bold represent statistically significant change after advanced meditation protocol.